Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Daisy Doyle plants 50 oak trees for Parkinson’s research
Last Autumn, 11 year old Daisy Doyle, granddaughter of Cure Parkinson’s co-founder Air Vice Marshal Michael Dicken and Patron Jenny Dicken, planted 50 oak trees on her family farm in Umberleigh, Devon in support of our research into a cure for Parkinson’s. Daisy chose to…
Cure Parkinson’s Raid Local 2021
On Sunday 27 June over 300 Cure Parkinson’s supporters from across the world jumped in the saddle to take on the charity’s Raid Local 2021: Ventoux! cycling challenge, raising awareness and over £53,000 for Parkinson’s research.
Encouraging trial results from Anavex
Recent positive results from biotech company Anavex Life Sciences have shown that when treated with their experimental drug, blarcamesine, individuals with Parkinson’s dementia had significant improvements in both motor and cognitive symptoms.
The Anavex results
This week some encouraging clinical trial results were announced by a biotech firm called Anavex Life Sciences. The company had been testing their lead experimental therapy – a Sigma-1 receptor agonist called ANAVEX2-73 (also known as blarcamesine) – in 132 people with Parkinson’s disease dementia over a 14 week period. The […]
EJS-ACT PD
This week an announcement was made regarding The Edmond J. Safra Accelerating Clinical Treatments for Parkinson’s Disease (EJS-ACT PD) Initiative. It is hoping to revolutionise the way clinical trials for potentially disease-modifying drugs for Parkinson’s are conducted. The project is focused on the setting up a multi-arm, multi-stage (MAMS) platform for […]